siRNA, Anti-MAPKAPK5, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT26397WQ-2OMe)
The product SIRGT26397WQ-2OMe is a type of small interfering RNA (siRNA) that targets MAPKAPK5 gene and regulates the expression of gene. The siRNA interferes with the expression of MAPKAPK5 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_003668.3; NM_139078.2 |
| Alternative Names | MAPKAP-K5; MK-5; MK5; PRAK |
| Related Diseases | Glioblastoma Mesenchymal Subtype |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT27397WQ-2F | MAPKAPK5 | Human | 2ʹ-deoxy-2ʹ-fluoro (2'-F) | ||
| SIRGT28397WQ-2MOE | MAPKAPK5 | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT29397WQ-LNA | MAPKAPK5 | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT26397WQ-RB | MAPKAPK5 | Human | Ribo-modified | ||
| SIRGT27397WQ-BB | MAPKAPK5 | Human | Backbone-modified |
